Logo-ps

 

 

 

Follower of ICMJE

Powered by:
Pharm Sci. 2017;23(2): 82-83. doi: 10.15171/PS.2017.13

Editorial

Whither QSAR?

John C. Dearden 1 *

Cited by CrossRef: 7

1- Ebenso E, Verma C, Olasunkanmi L, Akpan E, Verma D, Lgaz H, Guo L, Kaya S, Quraishi M. Molecular modelling of compounds used for corrosion inhibition studies: a review. Phys Chem Chem Phys. 2021;23(36):19987 [Crossref]
2- Hamzeh-Mivehroud M, Khoshravan-Azar Z, Dastmalchi S. QSAR and Molecular Docking Studies on Non-Imidazole-Based Histamine H3 Receptor Antagonists. Pharm Sci. 2020;26(2):165 [Crossref]
3- Kim K. Outliers in SAR and QSAR: 3. Importance of considering the role of water molecules in protein–ligand interactions and quantitative structure–activity relationship studies. J Comput Aided Mol Des. 2021;35(3):371 [Crossref]
4- Ghaemian P, Shayanfar A. Image-based QSAR Model for the Prediction of P-gp Inhibitory Activity of Epigallocatechin and Gallocatechin Derivatives. CAD. 2019;15(3):212 [Crossref]
5- Muthukumaran P, Rajiniraja M. Aug-MIA-QSAR based strategy in bioactivity prediction of a series of flavonoid derivatives as HIV-1 inhibitors. Journal of Theoretical Biology. 2019;469:18 [Crossref]
6- Shayanfar S, Shayanfar A. Comparison of various methods for validity evaluation of QSAR models. BMC Chemistry. 2022;16(1) [Crossref]

   Indexing & Abstracting: